Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: Rationale and design of a randomized, double-blind, placebo-controlled study

被引：0
|
作者：
Gladman, D
Keystone, E
Gottlieb, A
机构：
[1] Toronto Hosp, Western Div, Ctr Prognosis Studies, Toronto, ON M5T 2S8, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.229
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P227
引用
收藏
页码：P60 / P60
页数：1
相关论文
共 50 条
  • [31] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [32] Sulfasalazine in the treatment of juvenile chronic arthritis - A randomized, double-blind, placebo-controlled, multicenter study
    van Rossum, MAJ
    Fiselier, TJW
    Franssen, MJAM
    Zwinderman, AH
    ten Cate, R
    van Suijlekom-Smit, LWA
    van Luijk, WHJ
    van Soesbergen, RM
    Wulffraat, NM
    Oostveen, JCM
    Kuis, W
    Dijkstra, PF
    van Ede, CFP
    Dijkmans, BAC
    ARTHRITIS AND RHEUMATISM, 1998, 41 (05): : 808 - 816
  • [33] Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study
    Nettis, E
    Colanardi, MC
    Paradiso, MT
    Ferrannini, A
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (09): : 1401 - 1407
  • [34] Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
    Chen, Der-Yuan
    Chou, Show-Jan
    Hsieh, Tsu-Yi
    Chen, Yi-Hsing
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lan, Joung-Liang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (04) : 310 - 319
  • [35] BUSERELIN TREATMENT OF CRYPTORCHIDISM - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    BICA, DTG
    HADZISELIMOVIC, F
    JOURNAL OF UROLOGY, 1992, 148 (02): : 617 - 621
  • [36] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE TREATMENT OF THE PAINFUL SHOULDER
    PETRI, M
    DOBROW, R
    NEIMAN, R
    WHITINGOKEEFE, Q
    SEAMAN, WE
    ARTHRITIS AND RHEUMATISM, 1987, 30 (09): : 1040 - 1045
  • [37] Safety of alefacept in combination with methotrexate in the treatment of psoriatic arthritis
    Gladman, D
    Mease, P
    Keystone, E
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 324 - +
  • [38] A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis
    Aranow, Cynthia
    Cush, John
    Bolster, Marcy B.
    Striebich, Christopher C.
    Dall'era, Maria
    Mackay, Meggan
    Olech, Ewa
    Frech, Tracy
    Box, Jane
    Keating, Richard
    Wasko, Mary Chester
    St Clair, William
    Kivitz, Alan
    Huang, Weiquang
    Ricketts, PetaGay
    Welch, Beverly
    Callahan, Sherrie
    Spychala, Meagan
    Boyle, Karen
    York, Kate
    Keyes-Elstein, Lynette
    Goldmuntz, Ellen
    Diamond, Betty
    Davidson, Anne
    RHEUMATOLOGY, 2020, 59 (07) : 1505 - 1513
  • [39] TREATMENT OF ACTIVE RHEUMATOID-ARTHRITIS WITH SLOW INTRAVENOUS INJECTIONS OF THYMOPENTIN - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    MALAISE, MG
    FRANCHIMONT, P
    BACHANDERSEN, R
    GERBER, H
    STOCKER, H
    HAUWAERT, C
    DANNESKIOLDSAMSOE, B
    GROSS, D
    GERSCHPACHER, H
    BOLLA, K
    LANCET, 1985, 1 (8433): : 832 - 836
  • [40] Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial
    Mulder, Michelle L. M.
    Vriezekolk, Johanna E.
    van Hal, Tamara W.
    Nieboer, Lieke M.
    den Broeder, Nathan
    de Jong, Elke M. G. J.
    den Broeder, Alfons A.
    van den Hoogen, Frank H. J.
    Helliwell, Philip S.
    Wenink, Mark H.
    LANCET RHEUMATOLOGY, 2022, 4 (04): : E252 - E261
12345